Consensus-based recommendations for the management of juvenile dermatomyositis

Creative Commons License

Enders F. B., Bader-Meunier B., Baildam E., Constantin T., Dolezalova P., Feldman B. M., ...More

ANNALS OF THE RHEUMATIC DISEASES, vol.76, no.2, pp.329-340, 2017 (SCI-Expanded) identifier identifier identifier


Background In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile dermatomyositis (JDM) is a rare disease within the group of paediatric rheumatic diseases (PRDs) and can lead to significant morbidity. Evidence-based guidelines are sparse and management is mostly based on physicians' experience. Consequently, treatment regimens differ throughout Europe.